Literature DB >> 8974048

Cardiac pump function of the isolated rat heart at two modes of energy deprivation and effect of adrenergic stimulation.

V I Kapelko1, V L Lakomkin, O V Korchazhkina, O I Pisarenko.   

Abstract

The contractile function of the isolated rat heart and high energy phosphate content were evaluated under conditions of depressed energy supply caused by disturbances either in mitochondrial ATP production or ATP-phosphocreatine transformation. Amytal (0.3 mM), an inhibitor of mitochondrial respiration, or iodoacetamide (IAA, 0.1 mM) reducing in this dose creatine kinase activity to 19% of the initial level, were used, respectively. Myocardial ATP content remained unaffected in both groups and PCr content decreased to 37% only in amytal-treated group. Very similar alterations in cardiac pump function during volume load were observed in both treated groups; maximal cardiac output was significantly less by 30%, cardiac pressure-volume work by 38-40%, left ventricular (LV) systolic pressure by 24-29%, and LV +dP/dt by 36-39%. In contrast, the extent of decreased LV distensibility was different, a curve relating LV filling volume and end-diastolic pressure was shifted up and to the left much more prominently after IAA treatment. Heart rate was decreased by 24% only in amytal-treated group. Results indicate that a decreased myocardial distensibility is a dominating feature in the acute cardiac pump failure caused by an inhibition of myocardial creatine kinase. Isoproterenol (0.1 microM) substantially increased heart rate and pressure-rate product in IAA-treated hearts but failed to increase cardiac work probably due to its inability to improve myocardial distensibility.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8974048     DOI: 10.1007/bf00408649

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  17 in total

1.  Complete inhibition of creatine kinase in isolated perfused rat hearts.

Authors:  E T Fossel; H Hoefeler
Journal:  Am J Physiol       Date:  1987-01

2.  Reversible MM-creatine kinase binding to cardiac myofibrils.

Authors:  R Ventura-Clapier; V A Saks; G Vassort; C Lauer; G V Elizarova
Journal:  Am J Physiol       Date:  1987-09

3.  Energy transport from mitochondria to myofibril by a creatine phosphate shuttle in cardiac cells.

Authors:  G McClellan; A Weisberg; S Winegrad
Journal:  Am J Physiol       Date:  1983-11

4.  Cardiac contractile function, oxygen consumption rate and cytosolic phosphates during inhibition of electron flux by amytal--a 31P-NMR study.

Authors:  V V Kupriyanov; V L Lakomkin; O V Korchazhkina; V A Stepanov; V I Kapelko
Journal:  Biochim Biophys Acta       Date:  1991-07-05

5.  Creatine kinase in regulation of heart function and metabolism. II. The effect of phosphocreatine on the rigor tension of EGTA-treated rat myocardial fibers.

Authors:  V I Veksler; V I Kapelko
Journal:  Biochim Biophys Acta       Date:  1984-04-16

6.  Influence of isoproterenol on contractile protein function, excitation-contraction coupling, and energy turnover of isolated nonfailing human myocardium.

Authors:  G Hasenfuss; L A Mulieri; B J Leavitt; N R Alpert
Journal:  J Mol Cell Cardiol       Date:  1994-11       Impact factor: 5.000

7.  Regulation of cardiac energy turnover by coronary flow: a 31P-NMR study.

Authors:  V V Kupriyanov; O V Korchazhkina; V L Lakomkin
Journal:  J Mol Cell Cardiol       Date:  1993-10       Impact factor: 5.000

8.  Contractile failure and high-energy phosphate turnover during hypoxia: 31P-NMR surface coil studies in living rat.

Authors:  J A Bittl; J A Balschi; J S Ingwall
Journal:  Circ Res       Date:  1987-06       Impact factor: 17.367

9.  The cardiac contractile failure induced by chronic creatine and phosphocreatine deficiency.

Authors:  V I Kapelko; V V Kupriyanov; N A Novikova; V L Lakomkin; V I Veksler; V A Saks
Journal:  J Mol Cell Cardiol       Date:  1988-06       Impact factor: 5.000

10.  Role of creatine kinase in force development in chemically skinned rat cardiac muscle.

Authors:  R Ventura-Clapier; H Mekhfi; G Vassort
Journal:  J Gen Physiol       Date:  1987-05       Impact factor: 4.086

View more
  3 in total

1.  Inhibition of c-Jun-N-terminal kinase increases cardiac peroxisome proliferator-activated receptor alpha expression and fatty acid oxidation and prevents lipopolysaccharide-induced heart dysfunction.

Authors:  Konstantinos Drosatos; Zoi Drosatos-Tampakaki; Raffay Khan; Shunichi Homma; P Christian Schulze; Vassilis I Zannis; Ira J Goldberg
Journal:  J Biol Chem       Date:  2011-08-26       Impact factor: 5.157

Review 2.  Mitochondrial turnover in the heart.

Authors:  Roberta A Gottlieb; Asa B Gustafsson
Journal:  Biochim Biophys Acta       Date:  2010-12-13

Review 3.  Non-invasive investigation of myocardial energetics in cardiac disease using 31P magnetic resonance spectroscopy.

Authors:  Mark A Peterzan; Andrew J M Lewis; Stefan Neubauer; Oliver J Rider
Journal:  Cardiovasc Diagn Ther       Date:  2020-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.